Crossmark

DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study

Crossref DOI link: https://doi.org/10.1038/s41598-024-61615-0

Published Online: 2024-05-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Bolun

Xue, Junshuai

Xu, Bowen

Chang, Jianping

Li, Xin

Huang, Zhen

Zhao, Hong

Cai, Jianqiang
Funding

Funding for this research was provided by:

CAMS Initiative for Innovative Medicine (2021-I2M-1-015)

National Natural Science Foundation of China (81972311, 82141127)

the Sanming Project of Medicine in Shenzhen (No. SZSM202011010)

the CAMS Innovation Fund for Medical Sciences (No. 2021-I2M-1-066)
License Information

Text and Data Mining valid from 2024-05-10

Version of Record valid from 2024-05-10
More Information

Article History

Received: 16 January 2024

Accepted: 7 May 2024

First Online: 10 May 2024

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below